IPC -INTERNATIONAL SCIENTIFIC CONFERENCE ON PROBIOTICS, PREBIOTICS, GUT MICROBIOTA AND HEALTH 2026

IPC 2026: The Premier Global Summit on Gut Microbiota and Health

The International Scientific Conference on Probiotics, Prebiotics, Gut Microbiota and Health (IPC 2026), scheduled for June 22-24, 2026, in the historic and vibrant city of Krakow, Poland, stands as the premier global gathering for researchers, clinicians, industry professionals, and policymakers dedicated to advancing understanding and applications in the dynamic field of gut microbiome science. This triennial event, renowned for its scientific rigor and collaborative spirit, promises an unparalleled platform for cutting-edge discovery and knowledge exchange.

Scientific Core & Content Focus:
IPC 2026 will delve deep into the intricate interplay between probiotics, prebiotics, the gut microbiota, and human health. The conference content will span a comprehensive spectrum of critical topics, including:

1. Microbiota Dynamics & Mechanisms: Exploring the composition, function, resilience, and plasticity of the gut microbiome across the lifespan and in diverse populations. Sessions will cover metagenomics, metabolomics, and the role of microbial metabolites (SCFAs, tryptophan derivatives) in host physiology.
2. Probiotics & Synbiotics: Presenting the latest research on novel probiotic strains, their mechanisms of action (colonization, immune modulation, pathogen inhibition), efficacy in clinical trials for gastrointestinal disorders (IBS, IBD), metabolic health (obesity, diabetes), immune function, and mental health (the gut-brain axis). Focus will also be on synbiotic formulations and delivery systems.
3. Prebiotics & Dietary Fibers: Examining the impact of diverse prebiotics (inulin, FOS, GOS, resistant starches) and dietary fibers on microbiota composition, fermentation pathways, and health outcomes. Discussions will cover dose-response, structure-function relationships, and personalized nutrition approaches.
4. Gut Microbiota & Disease Pathogenesis: Investigating the role of dysbiosis in the development and progression of a wide array of conditions, including gastrointestinal diseases, metabolic syndrome, cardiovascular disorders, autoimmune conditions, neurodegenerative diseases, and cancer.
5. Therapeutic Applications & Translation: Highlighting advances in microbiota-based therapeutics, including next-generation probiotics, postbiotics, fecal microbiota transplantation (FMT), and phage therapy. Emphasis will be on clinical trial design, safety, regulatory pathways, and successful commercialization strategies.
6. Emerging Frontiers: Addressing cutting-edge areas such as virome and mycrome interactions, the maternal-offspring microbiome, microbiota and aging (longevity), environmental microbiota influences, and the potential of microbiome modulation for precision medicine and diagnostics.

Conference Format & Experience:
IPC 2026 will feature a rich program of plenary lectures by world-renowned experts, parallel thematic sessions covering diverse subtopics, interactive poster presentations showcasing the latest research, workshops on specific methodologies or applications, and industry symposia bridging science and commercialization. The conference fosters intense networking opportunities, encouraging collaboration between academia, healthcare, and industry. The choice of Krakow, a city steeped in scientific heritage and renowned for its academic institutions, provides an inspiring and accessible backdrop for this vital scientific exchange.

Mark your calendars for June 2026 in Krakow to be at the forefront of the revolution in gut microbiome science and its profound implications for global health. Stay tuned for the official call for papers and registration opening soon on the IPC website.